Marc Semigran
Corporate Officer/Principal chez EDGEWISE THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Marc Semigran
Sociétés | Poste | Début | Fin |
---|---|---|---|
EDGEWISE THERAPEUTICS, INC. | Corporate Officer/Principal | 20/12/2022 | - |
Harvard Medical School | Corporate Officer/Principal | 01/01/2010 | - |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts. | Consultant / Advisor | - | - |
Historique de carrière de Marc Semigran
Anciens postes connus de Marc Semigran
Sociétés | Poste | Début | Fin |
---|---|---|---|
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Chief Tech/Sci/R&D Officer | 01/06/2021 | 01/09/2021 |
MYOKARDIA, INC. | Chief Tech/Sci/R&D Officer | 01/12/2016 | 01/05/2021 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/04/2004 | 01/11/2016 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | 01/01/2004 | 01/01/2006 |
RENOVACOR, INC. | Chief Tech/Sci/R&D Officer | 01/09/2021 | - |
SOCL CAPI | Director/Board Member | 01/06/2021 | - |
Independent Dir/Board Member | 01/06/2021 | - |
Formation de Marc Semigran
Harvard University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 3 |
Finance | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
EDGEWISE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts. | Finance |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Health Technology |
Social Capital Suvretta Holdings Corp. III
Social Capital Suvretta Holdings Corp. III Financial ConglomeratesFinance Social Capital Suvretta Holdings Corp. III is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Henderson, NV. | Finance |
Renovacor, Inc.
Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Marc Semigran
- Expérience